Thromboelastography in Non-elective Cesarean Delivery
Trial ID or NCT#
Status
Purpose
The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.
Official Title
Thromboelastography to Assess Hemostatic Changes in Laboring Patients Undergoing Non-elective (Intrapartum) Cesarean Delivery
Eligibility Criteria
- - Obstetric in-patients - Laboring patients with Epidurals for Labor Analgesia going for non-elective Cesarean - Patients of all ethnic backgrounds will be included - Singleton pregnancy - ASA 1 or 2
- - Patients with underlying coagulation disorders. - Patients with thrombocytopenia (platelet count <100). - Patients with pregnancy-induced hypertension, pre-eclampsia. - Patients requiring the following medications prior to surgery: NSAIDS, aspirin, anticoagulants. - Patients requiring elective Cesarean delivery. - Patients with significant obstetric or medical disease. - No patients <18 years of age will be recruited.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Alexander J Butwick, MBBS, FRCA
6507368513
View on ClinicalTrials.gov